Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensity-modulated Radiation Therapy Combined With Cisplatin-based or Carboplatin-based Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma：: A Phase 3 Trial

NCT03919552 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT03919552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03919552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensity-modulated Radiation Therapy Combined With Cisplatin-based or Carboplatin-based Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma：: A Phase 3 Trial
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
January 31, 2018
Completion date
December 31, 2026
Enrollment
482 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carboplatin, cisplatin, npc